Torrance, C a l i f o r n i a , U.S.A. We have r e p o r t e d t h a t serum T3 i n t h e lamb i n c r e a s e s i n the newb o r n p e r i o d and t h a t , t h i s i n c r e a s e seems t o be provoked by c u t t i n g t h e u m b i l i c a l cord (CCT). To f u r t h e r c l a r i f y t h e r o l e o f TSH i n t h e newborn lamb we have s t u d i e d serum OTSH l e v e l s and t h e response t o exogenous TRH.
I n c o n t r o l s serum TSH l e v e l s i n c r e a s e d modestly t o peak l e v e l s (mean 215%) a t 30 min. A s i m i l a r 30-45 min. peak (mean 160;;) o c c u r r e d i n newborns i n which CCT i s delayed 60 min. I n s p i t e o f t h e e a r l y OTSH a t h e T3 response was delayed u n t i l a f t e r CCT. The response t o TRH (230 pg i n j e c t e d i n t r a v e n o u s l y ) was s t u d i e d i n 8 lambs. Four were under 6 h r s . o f age and 4 were between 7-18 h r . Blood was sampled s e r i a l l y f o r measurements o f TSH, p r o l a c t i n , T4 and T3. There was a r a p i d r i s e i n serum TSH and p r o l a c t i n conc. i n t h e f i r s t 15 min.: f r o m a mean o f 7.3 ~U / m l and 571 ng/n~l a t 0 t i m e t o 14.2 pU/m1 and 2130 ng/ml, r e s p e c t i v e l y . A second peak was observed a t 120 min. a f t e r TRH, b o t h f o r TSH (24.6 uU/ml) and p r ol a c t i n (2149 h g l m l ) , suggesting new s y n t h e s i s .and r e l e a s e . T4 and T3 l e v e l s began t o r i s e between 60 and 120 min. Peak l e v e l s were achieved 6 h r . a f t e r TRH: T4 A 12.6 t o 22.2 ug/100 ml and T3 A 221 t o 320 ng/100 ml . These data i n d i c a t e 1 ) the TSH response i n t h e newborn lamb i s much l e s s marked t h a n i n t h e newborn i n f a n t 2 ) t h e TSH and T3 were examined in 7 children with idiopathic short stature (SS), 6 with moderate obesity (ob), 7 with gross obesity (OB), and 3 juvenile diabetics (DB). Mean (fSE) plasma IRG (pglml) 4 children with a pituitary or hypothalamic tumor were studied. 3 of them underwent surgery. post-operatively a growth-spurt followed by normal growth as observed. One of these patients showed an excessive weight gain. The fourth patient in whom the tumor was not removed had a normal growth rate as well. In all 4 patients endocrine evaluation revealed varying degrees of anterior and posterior pituitary insufficiency. Peak GH levels following various stimuli were extremely low in all patients. Prolactin activity in serum as measured by a local pigeon crop assay was elevated in one patient onlv. In all patients the serum activity of somatomedin was determined by bioassay, serum levels of insulin were measured by RIA during stimulation tests; Our findings suggest that a biological suhstance other than GH might have induced somatomedin generation in these patients. Supported by Deutsche Forschungsgemeinschaft, SFB 34 REMARKABLE CATCH-UP GROWTH IN A BOY WITH THE NEPHRO-TIC SYNDROME, TREATED WITH PREDNISEIE. R.Steendijk, 51 Department of Paediatrics, University of Amsterdam.
In a boy, who got the nephrotic syndrome at the age of 4 years, growth and development were followed for 20 years. During this time glomerular function remained adequate. Initially, height was 101.5 cm (-0.8 SDS). During daily administration of prednisone in a dosage between 0.2 and 0.6 mglkglday, growth and development became retarded until -at the age of 15 years -height was 138.0 cm (-3.5 SDS) and S.A. (TANNER and WHITEHOUSE 11) was 8 years. From that time prednisone was given every other day or 3 times per week in a dosage which slowly decreased from 2 to 1 mglkglweek. Growth rate increased gradually from 1 cmlyear at the age of 14 years until 8 cmlyear at the age of 19 years, whilst the difference between C.A. and S.A. slowlv decreased. Puberty began at the age of 17 years. At the age of 24 years height was 171.5 cm (-1.0 SDS) and S.A. was 18.0 years. Noteworthy features were: 1) Anachronism between the RUS-and CBscores for S.A. amounting to 1.h -3.0 years during most of the time; and 2) a predicted adult hei~ht (TANNER et al., 1975) which was too low, the difference with achieved adult height being larger with increasing discrepancy between C.A. and S.A.
TESTICULAR ENDOCRINE FUNCTION IN PATIENTS TREATED
H. Stolecke, H. Olbing and H.-J.Bachmann, Children's Hospital, Department of Endocrinology and Nephrology, Univ. Essen, FRG. Reports of damaging effect of cyclophosphamide on the germinal epithelium led us to study as whether the endocrine function may be also involved in cyclophosphamide induced side effects. 5 boys aged 9-14 years suffering from nephrotic syndrome unresponsive to steroid therapy were treated for 6-9 weeks with cyclophosphamide 2.5-3.0 mglkg. Immediately after the end of the drugs period and a second time 13 till 28 months later they were examined by a stimulation test with HCG, using a single injection of 5000 IE/~' body surface i.m. Basal and 1, 3 and 5 days after HCG 24 hrs urine samples as well as plasma samples (at 9 a.m.) were analyzed for pregnanetriol (P30H) and for testosterone respectively. P30H was determined by GLC, T by RIA. In the 2nd seriesurinary P30H increment related to bone age was sufficient in 4 ~atients, but in 3 cases with a tendency to decrease while compared with the values immediately af ter the drugs period. Plasma T-values were normal under basal conditions. After HCG 2 patients increased their T-values as so far to be expected for a normal reaction, the 3 others showed a sluggish response only. From our results we suppose that cyclophosphamide therapy may involve a risk of a damaging effect also on the endocrine part of testicular function.
